Please assess the completion status of the following clinical trial:

Trial Title: Regorafenib Post-marketing Surveillance in Japan

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients who are treated with Regorafenib/ STIVARGA and meet the product label.~Exclusion Criteria:~* Patients who are treated with Regorafenib/ STIVARGA and don't meet the product label.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group 1 (Type: None): Patients treated with Regorafenib under practical manner for gastrointestinal stromal tumors progressed after cancer chemotherapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).